Welcome to
TMC Pharma
Your complete end-to-end partner for pharmaceutical development

TMC is a unique drug development organisation, offering a full range of support services to the Pharma and Biotech industries. We know that no two drug development programs are the same, and we therefore believe that, to maximise success, each client should receive a bespoke approach to their particular drug development requirements and challenges.

Here at TMC, we understand those challenges intimately, and our dedicated team of specialists and global Associates are ready to offer that expertise. Our team passionately believe that those affected by Orphan Disease should not feel marginalised in society by their conditions and our team is dedicated in bringing therapies to market that will allow those affected to live as normally as possible.


We cover all therapeutic areas but have particular expertise in:
- Rare and orphan diseases
- Advanced Therapy Investigational Medicinal Products
including stem cells and other cell-based therapies - Oncology including biologics and immuno-oncology
We have pioneered the early development pathway for novel advanced therapy agents; right from the manufacturing stage.


Each project team is hand-picked to match the needs of a client. The team evolve smoothly along with the progress of the project, responding intelligently to the specific needs at each stage of development, driving the project to a successful conclusion.
This approach makes us nimble, light on our feet, flexible and cost-effective.


TMC is working all over the Globe. We have offices and hubs in key countries – particularly in the EU, USA, UK and Japan.
Our core team of highly-experienced Senior Executives in TMC’s Head Office collaborate with our loyal and established network of Associates located around the world.
We are continuously engaging with new Associates as required in order to provide expert current, local knowledge.


Partnership:
The TMC Way Of Working
TMC came from a consultancy background. This makes us different from other service providers: we prefer to act as partners with our clients, providing a blend of consultancy/strategic advice and efficient implementation.
Our company has an outstanding track record of delivering successful projects across the following disciplines: